المؤلفون: Mavaddat, Nasim, Antoniou, Antonis, C., Mooij, Thea, Hooning, Maartje, Heemskerk-Gerritsen, Bernadette, Noguès, Catherine, Gauthier-Villars, Marion, Caron, Olivier, Gesta, Paul, Pujol, Pascal, Lortholary, Alain, Barrowdale, Daniel, Frost, Debra, Evans, D. Gareth, Izatt, Louise, Adlard, Julian, Eeles, Ros, Brewer, Carole, Tischkowitz, Marc, Henderson, Alex, Cook, Jackie, Eccles, Diana, van Engelen, Klaartje, Mourits, Marian, Ausems, Margreet, Koppert, Linetta, Hopper, John, John, Esther, Chung, Wendy, Andrulis, Irene, Daly, Mary, Buys, Saundra, Benitez, Javier, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, van Leeuwen, Flora, E., Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Engel, Christoph, Kast, Karin, Phillips, Kelly-Anne, Terry, Mary Beth, Milne, Roger, L, Goldgar, David, E., Rookus, Matti, A., Andrieu, Nadine, Easton, Douglas, F.

المساهمون: University of Cambridge UK (CAM), Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Erasmus MC Cancer Institute, Rotterdam, Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Curie Paris, Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Centre Hospitalier Georges Renon Niort (CH Georges Renon Niort), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Centre Catherine-de-Sienne Nantes (CCS), Manchester University NHS Foundation Trust (MFT), Guy's & St Thomas' NHS Foundation Trust, Chapel Allerton Hospital, University of Leeds, Royal Marsden NHS Foundation Trust, Royal Devon & Exeter Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Sheffield Children's NHS Foundation Trust, Wessex clinical genetics service, Vrije Universiteit Amsterdam Amsterdam (VU), University Medical Center Groningen Groningen (UMCG), Department of Medical Genetics, University Medical Center Utrecht, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Department of Epidemiology, Cancer Prevention Institute of California, Columbia University New York, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto-Cancer Care Ontario, Division of Population Science, Fox Chase Cancer Center, Department of Internal Medicine, Huntsman Cancer Institute, Departemento Genetica Humana, Centro Nacional Investigaciones Oncologicas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Madrid, Spain (IdISSC), Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec, Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, Medizinische Universität Wien = Medical University of Vienna, National Institute of Oncology, Masaryk Memorial Cancer Institute (MMCI), Masaryk University Brno (MUNI), Department of Clinical Genetics Copenhagen, Rigshospitalet Copenhagen, Copenhagen University Hospital-Copenhagen University Hospital, The Netherlands Cancer Institute Amsterdam, The Netherlands, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Dept of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Cancer Epidemiology Centre, Cancer Council Victoria, International Agency for Cancer Research (IACR), Netherlands Cancer Institute, Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe, Mines Paris - PSL (École nationale supérieure des mines de Paris), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Sciences et Lettres (PSL), Cancer Research U.K. Genetic Epidemiology Unit, Strangeways Research Laboratory

المصدر: ISSN: 1465-5411.

مصطلحات موضوعية: Mutation, Risk-reducing salpingo-oophorectomy, BRCA2, BRCA1, Breast cancer, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.GEN]Life Sciences [q-bio]/Genetics, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31948486; inserm-02445596; https://inserm.hal.science/inserm-02445596Test; https://inserm.hal.science/inserm-02445596/documentTest; https://inserm.hal.science/inserm-02445596/file/s13058-020-1247-4.pdfTest; PUBMED: 31948486; PUBMEDCENTRAL: PMC6966793

الإتاحة: https://doi.org/10.1186/s13058-020-1247-4Test
https://inserm.hal.science/inserm-02445596Test
https://inserm.hal.science/inserm-02445596/documentTest
https://inserm.hal.science/inserm-02445596/file/s13058-020-1247-4.pdfTest

المؤلفون: Mavaddat, Nasim, Antoniou, Antonis, C., Mooij, Thea, Hooning, Maartje, Heemskerk-Gerritsen, Bernadette, Noguès, Catherine, Gauthier-Villars, Marion, Caron, Olivier, Gesta, Paul, Pujol, Pascal, Lortholary, Alain, Barrowdale, Daniel, Frost, Debra, Evans, D. Gareth, Izatt, Louise, Adlard, Julian, Eeles, Ros, Brewer, Carole, Tischkowitz, Marc, Henderson, Alex, Cook, Jackie, Eccles, Diana, van Engelen, Klaartje, Mourits, Marian, Ausems, Margreet, Koppert, Linetta, Hopper, John, John, Esther, Chung, Wendy, Andrulis, Irene, Daly, Mary, Buys, Saundra, Benitez, Javier, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, van Leeuwen, Flora, E., Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Engel, Christoph, Kast, Karin, Phillips, Kelly-Anne, Terry, Mary Beth, Milne, Roger, L, Goldgar, David, E., Rookus, Matti, A., Andrieu, Nadine, Easton, Douglas, F.

المساهمون: University of Cambridge UK (CAM), Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Erasmus MC Cancer Institute, Rotterdam, Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Curie Paris, Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Centre Hospitalier Georges Renon Niort (CH Georges Renon Niort), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Centre Catherine-de-Sienne Nantes (CCS), Manchester University NHS Foundation Trust (MFT), Guy's & St Thomas' NHS Foundation Trust, Chapel Allerton Hospital, University of Leeds, Royal Marsden NHS Foundation Trust, Royal Devon & Exeter Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Sheffield Children's NHS Foundation Trust, Wessex clinical genetics service, Vrije Universiteit Amsterdam Amsterdam (VU), University Medical Center Groningen Groningen (UMCG), Department of Medical Genetics, University Medical Center Utrecht, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Department of Epidemiology, Cancer Prevention Institute of California, Columbia University New York, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto-Cancer Care Ontario, Division of Population Science, Fox Chase Cancer Center, Department of Internal Medicine, Huntsman Cancer Institute, Departemento Genetica Humana, Centro Nacional Investigaciones Oncologicas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Madrid, Spain (IdISSC), Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec, Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, Medizinische Universität Wien = Medical University of Vienna, National Institute of Oncology, Masaryk Memorial Cancer Institute (MMCI), Masaryk University Brno (MUNI), Department of Clinical Genetics Copenhagen, Rigshospitalet Copenhagen, Copenhagen University Hospital-Copenhagen University Hospital, The Netherlands Cancer Institute Amsterdam, The Netherlands, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Dept of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Cancer Epidemiology Centre, Cancer Council Victoria, International Agency for Cancer Research (IACR), Netherlands Cancer Institute, Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe, Mines Paris - PSL (École nationale supérieure des mines de Paris), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Sciences et Lettres (PSL), Cancer Research U.K. Genetic Epidemiology Unit, Strangeways Research Laboratory

المصدر: ISSN: 1465-5411.

مصطلحات موضوعية: Mutation, Risk-reducing salpingo-oophorectomy, BRCA2, BRCA1, Breast cancer, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.GEN]Life Sciences [q-bio]/Genetics, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31948486; inserm-02445596; https://inserm.hal.science/inserm-02445596Test; https://inserm.hal.science/inserm-02445596/documentTest; https://inserm.hal.science/inserm-02445596/file/s13058-020-1247-4.pdfTest; PUBMED: 31948486; PUBMEDCENTRAL: PMC6966793

الإتاحة: https://doi.org/10.1186/s13058-020-1247-4Test
https://inserm.hal.science/inserm-02445596Test
https://inserm.hal.science/inserm-02445596/documentTest
https://inserm.hal.science/inserm-02445596/file/s13058-020-1247-4.pdfTest

المؤلفون: Mavaddat, Nasim, Antoniou, Antonis, Mooij, Thea, Hooning, Maartje, Heemskerk-Gerritsen, Bernadette, Noguès, Catherine, Gauthier-Villars, Marion, Caron, Olivier, Gesta, Paul, Pujol, Pascal, Lortholary, Alain, Barrowdale, Daniel, Frost, Debra, Evans, D. Gareth, Izatt, Louise, Adlard, Julian, Eeles, Ros, Brewer, Carole, Tischkowitz, Marc, Henderson, Alex, Cook, Jackie, Eccles, Diana, van Engelen, Klaartje, Mourits, Marian, Ausems, Margreet, Koppert, Linetta, Hopper, John, John, Esther, Chung, Wendy, Andrulis, Irene, Daly, Mary, Buys, Saundra, Benitez, Javier, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Van Leeuwen, Flora, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Engel, Christoph, Kast, Karin, Phillips, Kelly-Anne, Terry, Mary Beth, Milne, Roger, Goldgar, David, Rookus, Matti, Andrieu, Nadine, Easton, Douglas

المساهمون: University of Cambridge UK (CAM), Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Erasmus MC Cancer Institute, Rotterdam, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Curie Paris, Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Centre Hospitalier Georges Renon Niort (CH Georges Renon Niort), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Centre Catherine-de-Sienne Nantes (CCS), Manchester University NHS Foundation Trust (MFT), Guy's & St Thomas' NHS Foundation Trust, Chapel Allerton Hospital, University of Leeds, Royal Marsden NHS Foundation Trust, Royal Devon & Exeter Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Sheffield Children's NHS Foundation Trust, Wessex clinical genetics service, Vrije Universiteit Amsterdam Amsterdam (VU), University Medical Center Groningen Groningen (UMCG), Department of Medical Genetics, University Medical Center Utrecht, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Department of Epidemiology, Cancer Prevention Institute of California, Columbia University New York, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto-Cancer Care Ontario, Division of Population Science, Fox Chase Cancer Center, Department of Internal Medicine, Huntsman Cancer Institute, Departemento Genetica Humana, Centro Nacional Investigaciones Oncologicas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Madrid, Spain (IdISSC), Department of Genetics and Pathology, Pomeranian Medical University-International Hereditary Cancer Centre, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec, Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, Medizinische Universität Wien = Medical University of Vienna, National Institute of Oncology, Masaryk Memorial Cancer Institute (RECAMO), Masaryk University Brno (MUNI), Department of Clinical Genetics Copenhagen, Rigshospitalet Copenhagen, Copenhagen University Hospital-Copenhagen University Hospital, The Netherlands Cancer Institute Amsterdam, The Netherlands, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Lund University Hospital, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Universität Leipzig Leipzig, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Dept of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Department of Epidemiology Columbia University, Columbia Mailman School of Public Health-Columbia University New York, Cancer Epidemiology Centre, Cancer Council Victoria, International Agency for Cancer Research (IACR), Netherlands Cancer Institute, Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe, Institut Curie Paris -MINES ParisTech - École nationale supérieure des mines de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris sciences et lettres (PSL), Cancer Research U.K. Genetic Epidemiology Unit, Strangeways Research Laboratory

المصدر: ISSN: 1465-5411 ; Breast Cancer Research ; https://www.hal.inserm.fr/inserm-02445596Test ; Breast Cancer Research, BioMed Central, 2020, 22 (1), pp.8. ⟨10.1186/s13058-020-1247-4⟩.

مصطلحات موضوعية: Breast cancer, Mutation, BRCA2, Risk-reducing salpingo-oophorectomy, BRCA1, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.GEN]Life Sciences [q-bio]/Genetics, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31948486; inserm-02445596; https://www.hal.inserm.fr/inserm-02445596Test; https://www.hal.inserm.fr/inserm-02445596/documentTest; https://www.hal.inserm.fr/inserm-02445596/file/s13058-020-1247-4.pdfTest; PUBMED: 31948486; PUBMEDCENTRAL: PMC6966793

الإتاحة: https://doi.org/10.1186/s13058-020-1247-4Test
https://www.hal.inserm.fr/inserm-02445596Test
https://www.hal.inserm.fr/inserm-02445596/documentTest
https://www.hal.inserm.fr/inserm-02445596/file/s13058-020-1247-4.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht (UMCU), Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, University of Melbourne, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht (UMCU), Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, University of Melbourne, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht, Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht, Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, University of Melbourne, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht, Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, McDonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, Daly, Mary, Friedlander, Michael, McLachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, Van Leeuwen, Flora, Goldgar, David, Milne, Roger, Easton, Douglas, Rookus, Matti, Andrieu, Nadine

المساهمون: Department of Epidemiology Columbia University, Columbia Mailman School of Public Health-Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Universität Leipzig Leipzig, Laboratoire d'Oncogénétique, CRLCC René Huguenin, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht, Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, Pomeranian Medical University-International Hereditary Cancer Centre, Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Lund University Hospital, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, University of Utah School of Medicine Salt Lake City, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://www.hal.inserm.fr/inserm-02438434Test ; JNCI Cancer Spectrum, Oxford University Press, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://www.hal.inserm.fr/inserm-02438434Test; https://www.hal.inserm.fr/inserm-02438434/documentTest; https://www.hal.inserm.fr/inserm-02438434/file/pky078.pdfTest; PUBMEDCENTRAL: PMC6405439; PUBMED: 30873510

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://www.hal.inserm.fr/inserm-02438434Test
https://www.hal.inserm.fr/inserm-02438434/documentTest
https://www.hal.inserm.fr/inserm-02438434/file/pky078.pdfTest

المؤلفون: Terry, Mary Beth, Liao, Yuyan, Kast, Karin, Antoniou, Antonis, C., Mcdonald, Jasmine, Mooij, Thea, Engel, Christoph, Noguès, Catherine, Buecher, Bruno, Mari, Veronique, Moretta-Serra, Jessica, Gladieff, Laurence, Luporsi, Elisabeth, Barrowdale, Daniel, Frost, Debra, Henderson, Alex, Brewer, Carole, Evans, D Gareth, Eccles, Diana, Cook, Jackie, Ong, Kai-Ren, Izatt, Louise, Ahmed, Munaza, Morrison, Patrick, Dommering, Charlotte, Oosterwijk, Jan, Ausems, Margreet, Kriege, Mieke, Buys, Saundra, Andrulis, Irene, John, Esther, M., Daly, Mary, B., Friedlander, Michael, Mclachlan, Sue Anne, Osorio, Ana, Caldés, Trinidad, Jakubowska, Anna, Simard, Jacques, Singer, Christian, Tan, Yen, Olah, Edith, Navratilova, Marie, Foretova, Lenka, Gerdes, Anne-Marie, Roos-Blom, Marie-José, Arver, Brita, Olsson, Håkan, Schmutzler, Rita, Hopper, John, van Leeuwen, Flora, E., Goldgar, David, E., Milne, Roger, L, Easton, Douglas, Rookus, Matti, A., Andrieu, Nadine, N.

المساهمون: Department of Epidemiology Columbia University, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York, Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Centre for Cancer Genetic Epidemiology, University of Cambridge UK (CAM), Institute for Medical Informatics, Statistics and Epidemiology Leipzig (IMISE), Leipzig University / Universität Leipzig, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Service de Génétique Oncologique, Institut Curie Paris, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Institut Claudius Regaud, Centre Alexis Vautrin (CAV), Newcastle Upon Tyne Hospitals NHS Trust, Department of Clinical Genetics, Royal Devon & Exeter Hospital, St Mary's Hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Northern Ireland Regional Genetics Centre, Belfast City Hospital, Department of Clinical Genetics and Human Genetics, VU University Medical Center Amsterdam, Department of Genetics, Department of Medical Genetics, University Medical Center Utrecht, Erasmus University Medical Center Rotterdam (Erasmus MC)-Family Cancer Clinic, Department of Internal Medicine, Huntsman Cancer Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Epidemiology, Cancer Prevention Institute of California, Division of Population Science, Fox Chase Cancer Center, Dept of Medical Oncology, Division of Medicine, University of New South Wales Sydney (UNSW)-Prince of Wales Hospital Randwick, Human Genetics Group, Spanish National Cancer Research Centre, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Department of Genetics and Pathology, International Hereditary Cancer Centre-Pomeranian Medical University Szczecin (PUM), Laboratoire de Génomique des Cancers, Université Laval Québec (ULaval), Division of Special Gynecology, Medizinische Universität Wien = Medical University of Vienna-Department of OB/GYN, National Institute of Oncology, Masaryk University Brno (MUNI), Odense University Hospital, Radiumhemmet, Karolinska University Hospital Stockholm, Department of Oncology, Skane University Hospital Lund, Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, Clinical Center Un, Centre for MEGA Epidemiology, The University of Melbourne, Victoria, Australia, Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Department of Dermatology, School of Medicine University of Utah, Salt Lake City, University of Utah-University of Utah, Cancer Epidemiology Centre, Cancer Council Victoria, Centre for Cancer Genetic Epidemiology Cambridge, University of Cambridge UK (CAM)-Department of Oncology, Netherlands Cancer Institute, Innovation et Développement dans l'Agriculture et l'Alimentation (UMR Innovation), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), This work was supported by grants to kConFab and the kConFab Follow-Up Study from Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the National Health and Medical Research Council (454508, 288704, 145684), the US National Institute of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. MODSQUAD Czech Republic, Brno was supported by MH CZ—DRO (MMCI, 00209805) and by MEYS—NPS I - LO1413 to LF, MN. The Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research grants KTIA-OTKA CK80745 and NKFI OTKA K-112228 and the Norwegian EEA Financial Mechanism HU0115/NA/2008-3/OP-9. € Lund-BRCA collaborators are supported by the Swedish Cancer Society, Lund Hospital Funds, and European Research Council Advanced grant ERC-2011-294576. Stockholm-BRCA collaborators are supported by the Swedish Cancer Society., European Project: 294576,EC:FP7:ERC,ERC-2011-ADG_20110310,RISK FACTORS CANCER(2012)

المصدر: EISSN: 2515-5091 ; JNCI Cancer Spectrum ; https://inserm.hal.science/inserm-02438434Test ; JNCI Cancer Spectrum, 2018, 2 (4), pky078. ⟨10.1093/jncics/pky078⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN]Life Sciences [q-bio]/Genetics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30873510; info:eu-repo/grantAgreement/EC/FP7/294576/EU/Genetic and environmental risk factors for common malignant tumours especially breast cancer and melanoma./RISK FACTORS CANCER; inserm-02438434; https://inserm.hal.science/inserm-02438434Test; https://inserm.hal.science/inserm-02438434/documentTest; https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest; PUBMED: 30873510; PUBMEDCENTRAL: PMC6405439

الإتاحة: https://doi.org/10.1093/jncics/pky078Test
https://inserm.hal.science/inserm-02438434Test
https://inserm.hal.science/inserm-02438434/documentTest
https://inserm.hal.science/inserm-02438434/file/pky078.pdfTest